ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Valluvan Jeevanandam
James B. McClurken
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeevanandam, V.
Right arrow Articles by McClurken, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeevanandam, V.
Right arrow Articles by McClurken, J. B.

Ann Thorac Surg 1996;62:1268-1275
© 1996 The Society of Thoracic Surgeons

Original Article: Cardiovascular

Standard Criteria for an Acceptable Donor Heart Are Restricting Heart Transplantation

Valluvan Jeevanandam, MD, Satoshi Furukawa, MD, Thomas W. Prendergast, MD, Barbara A. Todd, CRNP, Howard J. Eisen, MD, James B. McClurken, MD

Sections of Cardiothoracic Surgery and Cardiology, Temple University Health Sciences Center, Philadelphia, Pennsylvania

Background. The lack of satisfactory donor organs limits heart transplantation. The purpose of this study was to determine whether the criteria for suitability of donors may be safely expanded.

Methods. One hundred ninety-six heart transplantations were performed on 192 patients at our institution from January 1992 to 1995 and were divided into two groups. Group A donors (n = 113) conformed to the standard criteria. Group B donors (n = 83) deviated by at least one factor and consisted of the following: 16 hearts from donors greater than 50 years of age, 33 with myocardial dysfunction (echocardiographic ejection fraction = 0.35 ± 0.10, dopamine level exceeding 20 µg•kg-1•min-1, and resuscitation with triiodothyronine), 33 undersized donors with donor to recipient weight ratios of 0.45 ± 0.04, 48 with extended ischemic times of 297.4 ± 53.6 minutes, 25 with positive blood cultures, 16 with positive hepatitis C antibody titers, and 7 with conduction abnormalities (Wolff-Parkinson-White syndrome, prolonged QT interval, bifascicular block).

Results. Thirty-day mortality was 6.2% (7/113) in group A and 6.0% (5/83) in group B. Mortality in group A was attributed to 3 patients with myocardial dysfunction, 2 with infection, 1 with acute rejection, and 1 with pancreatitis; group B had 2 with myocardial dysfunction, 1 with infection, 1 with aspiration, and 1 with bowel infarction. At 12 months, survival and hemodynamic indices were similar between the groups. Of the 16 recipients with hepatitis C–positive hearts, 5 have become hepatitis C positive with mild hepatitis (follow up, 6 to 30 months).

Conclusions. Expanding the criteria for suitability of donor hearts dramatically increases the number of transplantations without compromising recipient outcome.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
S. Goland, L. S.C. Czer, R. M. Kass, R. J. Siegel, J. Mirocha, M. A. De Robertis, J. Lee, S. Raissi, W. Cheng, G. Fontana, et al.
Use of Cardiac Allografts With Mild and Moderate Left Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1214 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
K. J. Shea, N. A Sopko, K. Ludrosky, K. Hoercher, N. G. Smedira, D. O. Taylor, R. C. Starling, and G. V. Gonzalez-Stawinski
The effect of a donor's history of active substance on outcomes following orthotopic heart transplantation
Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 452 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
L. Dvorak, J. Pirk, S. Cerny, and J. Kovar
The role of leukocyte depleting filters in heart transplantation: early outcomes in prospective, randomized clinical trial.
Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 621 - 627.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. L. Navia, F. A. Atik, A. Marullo, R. C. Starling, M. Garcia, P. R. Vega, N. G. Smedira, and P. M. McCarthy
Bench Repair of Donor Aortic Valve With Minimal Access Orthotopic Heart Transplantation
Ann. Thorac. Surg., July 1, 2005; 80(1): 313 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. E. Newcomb, D. S. Esmore, F. L. Rosenfeldt, M. Richardson, and S. F. Marasco
Heterotopic Heart Transplantation: An Expanding Role in the Twenty-First Century?
Ann. Thorac. Surg., October 1, 2004; 78(4): 1345 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. S. Poston, J. Gu, D. Prastein, F. Gage, J. W. Hoffman, M. Kwon, A. Azimzadeh, R. N. Pierson III, and B. P. Griffith
Optimizing Donor Heart Outcome After Prolonged Storage With Endothelial Function Analysis and Continuous Perfusion
Ann. Thorac. Surg., October 1, 2004; 78(4): 1362 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. A. G. Solomon, J. R. McGiven, P. M. Alison, P. N. Ruygrok, D. A. Haydock, H. A. Coverdale, and T. M. West
Changing donor and recipient demographics in a heart transplantation program: influence on early outcome
Ann. Thorac. Surg., June 1, 2004; 77(6): 2096 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
H. Laks, D. Marelli, G. C. Fonarow, M. A. Hamilton, A. Ardehali, J. D. Moriguchi, J. Bresson, D. Gjertson, and J. A. Kobashigawa
Use of two recipient lists for adults requiring heart transplantation
J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 49 - 59.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. G. Zaroff, B. R. Rosengard, W. F. Armstrong, W. D. Babcock, A. D'Alessandro, G. W. Dec, N. M. Edwards, R. S. Higgins, V. Jeevanandum, M. Kauffman, et al.
Consensus Conference Report: Maximizing Use of Organs Recovered From the Cadaver Donor: Cardiac Recommendations March 28-29, 2001, Crystal City, Va
Circulation, August 13, 2002; 106(7): 836 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. C. Canver and J. Chanda
Heart transplantation
Ann. Thorac. Surg., August 1, 2001; 72(2): 658 - 660.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. B. Luciani, G. Faggian, G. Montalbano, G. Casali, A. Forni, B. Chiominto, and A. Mazzucco
BLOOD VERSUS CRYSTALLOID CARDIOPLEGIA FOR MYOCARDIAL PROTECTION OF DONOR HEARTS DURING TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL
J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 787 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Vijay, V. A. Scavo, R. J. Morelock, T. G. Sharp, and J. W. Brown
Donor cardiac troponin T: a marker to predict heart transplant rejection
Ann. Thorac. Surg., December 1, 1998; 66(6): 1934 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. W. Prendergast, S. Furukawa, A. J. Beyer III, B. J. Browne, H. J. Eisen, and V. Jeevanandam
The Role of Gender in Heart Transplantation
Ann. Thorac. Surg., January 1, 1998; 65(1): 88 - 94.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.